In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Celsis International Ltd.

http://www.celsis.com

Latest From Celsis International Ltd.

Deals In Depth: June/July 2015

Sanofi and Regeneron teamed up in a second major deal, focused on immuno-oncology; after an unsuccessful try at Mylan, Teva bought Allergan's generics business. Between June and July, biopharma companies raised over $10 billion, and device firms more than $1 billion.

BioPharmaceutical Medical Device

Medical Device Deals Update, August 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced June-July 2015.

Medical Device Deals

Merlin's Consolidation Wizardry

If there is plenty of start-up capital in Europe, the problem is at the next financing stages, says Chris Evans, the founder and chairman of Merlin Biosciences. Not even a small fraction of the current start-ups will be able to raise their next round of funding. Merlin's hands-on venture investing will lead it to play the consolidator among Europe's start-ups.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Services
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
UsernamePublicRestriction

Register